+1 (800) 559-9921
A Collaboration for Progress
MRM Proteomics, Inc. (MRMP) and Agilent Technologies Inc. are excited to announce their new co-marketing agreement aimed to further advance the capabilities of quantitative proteomic applications and thereby help the scientific community make impactful, novel scientific discoveries.
This new partnership will provide a complete solution for quantitative protein and metabolite analysis. Agilent’s advanced expertise and state-of-the-art mass spectrometry technology, along with MRMP’s leadership and experience in peptide and metabolite quantitation will enable the development of new tools and technologies to advance the field of multi-omics.
Easy-to-use Turn-Key Solution
New and expanded PeptiQuant Plus kit: Our Human Plasma kit has enlarged it’s panel to allow 270 proteins to be quantified from a single sample.
The Potential of Structural Proteomics for Treating Neurodegenerative Diseases
The highly influential journal “Chemical Reviews” recently published a review where our CSO and Co-founder Christoph Borchers and McGill scientist Evgeniy Petrotchenko discuss the potential of structural proteomics for treating neurodegenerative diseases.“This field combines protein chemistry and mass spectrometry, an advanced analytical technique for identifying the chemical composition of substances based on precise mass. The ultimate goal is to resolve the detailed structure of proteins and therefore understand pathological processes, like Alzheimer’s, on the molecular level and predict drug candidates against diverse diseases faster and more efficiently.”“We are looking at hundreds of protein-protein interactions at a time. We are looking at the entire protein network. This cannot be done by other techniques,” Christoph Borchers stated. “Same as with an orchestra: You have to consider the whole thing.” “We are looking at hundreds of protein-protein interactions at a time. We are looking at the entire protein network. This cannot be done by other techniques,” Christoph Borchers stated. “Same as with an orchestra: You have to consider the whole thing.”To read Technology networks full news article: bit.ly/3s4iNx2<br< span=””></br<>
Advancing Proteomics Technology
MRM Proteomics Inc. is at the leading edge of proteomics technology. We offer a wide variety of proteomics services for protein quantitation, structural characterization, tissue imaging and a line of easy-to-use proteomics kits.
SERVICES
MRM Proteomics Inc. offers a wide range of services to fit a wide variety of projects…
PRODUCTS
Our complementary line of quality control products will help to ensure that your …
CLINICAL DIAGNOSTICS
The development of laboratory-developed tests (LDTs) will provide health-care…